Neuromodulation Market Scope And Analysis

  • Report Code : TIPHE100001415
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Neuromodulation Market Analysis and Scope 2021-2031

Buy Now

Neuromodulation Market Report Neuromodulation Market Size and Share Neuromodulation Market Scope and Analysis

Neuromodulation Market Report Scope

Report Attribute Details
Market size in 2021 US$ 8.87 Billion
Market Size by 2031 US$ 28.32 Billion
Global CAGR (2023 - 2031) 15.2%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Technology
  • External
By Application
  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson Diseases
  • Obsessive-Complusive Disorder
  • Migraine
By End User
  • Hospitals
  • Clinics
  • Home Healthcare
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace Inc
  • NeuroSigma Inc
  • NEVRO CORP
  • Synapse Biomedical Inc
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim